Abstract
A 29-year-old male developed ocular flutter and subtle extremity myoclonus related to demyelination. Ocular flutter and myoclonus were symptomatically amenable to treatment with levetiracetam. Discontinuation of levetiracetam was associated with recurrent flutter and myoclonus over a two-year period of follow-up. Levetiracetam may be an effective agent for the symptomatic control of ocular flutter.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
